Pacemaker News and Research

RSS

Medtronic receives FDA approval for BrainSense Adaptive DBS technology

For the one million people diagnosed with Parkinson's disease in the United States, Medtronic plc (NYSE:MDT), a global leader in healthcare technology, proudly announces U.S. Food and Drug Administration (FDA) approval of BrainSense™ Adaptive deep brain stimulation (aDBS) and BrainSense™ Electrode Identifier (EI).

3 Mar 2025

Understanding the causes and symptoms of obstructive sleep apnea

Do you feel tired or have a headache when you wake up in the morning? Something might be going wrong while you sleep that you don't know about: obstructive sleep apnea (pronounced app-nee-uh).

24 Feb 2025

UC Davis surgeon pioneers dual chamber leadless pacemaker in 13-year-old patient

UC Davis Director of Pediatric Electrophysiology Dan Cortez has set another world record: He is the first to implant a dual chamber leadless pacemaker in a child.

20 Dec 2024

New biomaterials improve signal-to-noise ratio in brain pacemakers

Two years ago, a medical professional approached scientists at the University of Tabriz in Iran with an interesting problem: Patients were having headaches after pacemaker implants. Working together to investigate, they began to wonder if the underlying issue is the materials used in the pacemakers.

11 Dec 2024

The heart has a mini-brain that controls its rhythm

New research from Karolinska Institutet and Columbia University shows that the heart has a mini-brain - its own nervous system that controls the heartbeat.

4 Dec 2024

Reconditioned pacemakers prove safe and effective in global trial

A randomized trial that compared previously used and new pacemakers in patients found the reconditioned devices were as safe and effective as new pacemakers, potentially offering affordable options for patients in low-and middle-income countries.

18 Nov 2024

A father's journey from emergency response to a career at NYU Langone Health

The scream that Jonathan Negron heard on a commercial airline flight five years ago ultimately signaled his pathway to a career with NYU Langone Health, one inspired by the quick diagnosis of his daughter's exceedingly rare condition.

12 Nov 2024

Research unveils method for defibrillation using less energy

In a paper published this week in Chaos, by AIP Publishing, researchers from Sergio Arboleda University in Bogotá, Colombia, and the Georgia Institute of Technology in Atlanta used an electrophysiological computer model of the heart's electrical circuits to examine the effect of the applied voltage field in multiple fibrillation-defibrillation scenarios.

5 Nov 2024

Researchers unlock potential of light-controlled cellular activities

Researchers at the Paul Scherrer Institute PSI have succeeded in elucidating the structure of specific photoreceptors.

25 Oct 2024

Bright night light exposure increases mortality risk, while daylight reduces it

Study reveals that brighter night light exposure and circadian rhythm disruption significantly increase the risk of mortality, particularly from cardiometabolic diseases, while brighter daytime light lowers these risks.

16 Oct 2024

Researchers use smartphone data for early detection of Alzheimer's

Researchers from DZNE and Otto von Guericke University Magdeburg have identified individuals with increased risk for dementia using mobility data, recorded during a smartphone-based wayfinding task on the university campus.

3 Oct 2024

Implantable device revolutionizes thyroid management

A Carnegie Mellon University-led team has secured an award of up to $42 million from the Advanced Research Projects Agency for Health (ARPA-H) to accelerate the development of implantable, cell-based bioelectronic devices that deliver patient-specific therapy and monitor disease status, for conditions like hypo- and hyperthyroidism, in real time.

3 Oct 2024

Disruption of circadian clock linked to accelerated colorectal cancer progression

Research from the University of California, Irvine has revealed how disruption of the circadian clock, the body's internal, 24-hour biological pacemaker, may accelerate the progression of colorectal cancer by affecting the gut microbiome and intestinal barrier function.

27 Sep 2024

Study reveals impact of human breast milk on infant microbiome and respiratory health

Human breast milk regulates a baby's mix of microbes, or microbiome, during the infant's first year of life. This in turn lowers the child's risk of developing asthma, a new study shows.

19 Sep 2024

TAVI outperforms surgery in reducing complications for women with severe aortic stenosis

Transcatheter aortic valve implantation (TAVI) was superior to surgical aortic valve replacement for reducing death, stroke or rehospitalization in women with severe aortic stenosis, according to late-breaking research presented in a Hot Line session today at ESC Congress 2024.

1 Sep 2024

Self-assembling heart stimulator can correct heart arrhythmia in emergency situations

By injecting a solution of nanoparticles around the heart, a temporary heart stimulator self-assembles, which can correct heart arrhythmia in emergency situations with the help of an external power source.

27 Aug 2024

New ESC atlas data highlights disparities in cardiovascular disease mortality

Cardiovascular disease (CVD) remains the most common cause of death across Europe but while CVD mortality rates are generally decreasing, the decline is much less in middle-income than in high-income countries, according to new data from the European Society of Cardiology (ESC) Atlas of Cardiology, published in the European Heart Journal.

27 Aug 2024

Commonly used anesthetic drug can restore the function of ion channel linked to epilepsy

Mutated variants of a particular ion channel cause difficult-to-treat epilepsy. A study published in the journal Nature now shows that a commonly used anesthetic drug, propofol, can restore the function of this ion channel.

31 Jul 2024

Propofol shows potential for treating epilepsy and neurological disorders

The general anesthetic propofol may hold the keys to developing new treatment strategies for epilepsy and other neurological disorders, according to a study led by researchers at Weill Cornell Medicine and Linköping University in Sweden.